SAN FRANCISCO -- Bisphenol A, a chemical that leaches into food and beverages from many consumer products, causes normal, non-cancerous human breast cells to express genes characteristic of aggressive breast cancer cells. That's the finding of a "Priority Report" in

Pro-Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of DAVANAT(R) in combination with chemotherapy and biologic to treat a breast cancer patient. The Company currently has two

Researchers detail in 'Is mode of breast cancer detection associated with cancer treatment in the United States,' new data in breast cancer. "The prognosis for women who have breast cancer detected by mammography is more favorable than that for women

GeneNews reported positive performance results from a large validation study of a six-gene biomarker panel for the assessment of a patient's current risk for colorectal cancer.